RA Capital Management's Biopharma Portfolio

ARS Pharmaceuticals is a stealth pharmaceutical company that specializes in developing anti allergy drugs.

KalVista Pharmaceuticals focuses on developing oral medicines, particularly for managing hereditary angioedema.

Monopar Therapeutics is an emerging biopharmaceutical company focused on developing orphan oncology compounds.

Hyku is a biotech company that develops precise covalent targeting of disease-causing proteins.

HilleVax is a biopharmaceutical company that focuses on the development and commercialization of novel vaccines.

Point Biopharma focused on the development and commercialization of radioligand therapies for the treatment of cancer.

Day One Biopharmaceuticals develops targeted therapies to treat people with life-threatening diseases.

Imara is provider of novel therapeutics for the people living with sickle cell disease and hemoglobinopathies.

Jade Biosciences is developing transformative therapies to redefine the standard of care for inflammation and immunology indications.

Mineralys Therapeutics is a clinical-stage biopharmaceutical company committed to developing therapy for the treatment of hypertension.

ALX Oncology is a preclinical stage biotechnology company developing innovative immuno-oncology therapies for cancer.

Frontier Medicines is a biopharmaceutical company that develops a chemoproteomics platform to accelerate the development of medicines.

Ollin Biosciences develops ophthalmic therapies focused on treating serious vision-threatening diseases.

Aurinia develops and commercializes therapies to treat targeted patient populations suffering from serious auto-immune diseases.

Parabilis Medicines is a Grupo Bugio is a biopharmaceutical firm that specializes in creating medicines.

SonoThera develops ultrasound-based technologies for delivering genetic therapies to targeted tissues.

cAMPfield Therapeutics is a biotechnology company that specializes on exploration and development activities of therapeutic solutions.

Stipple Bio is a biotechnology company that offers cellular profiling and target discovery with epitope resolution.

GH Research is a biopharmaceutical company developing novel therapies for the management of mental illness.

Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.

Prelude Therapeutics designs and develops small molecule therapies targeting key drivers of cancer cell growth and resistance.

Palisade Bio is a clinical-stage biopharmaceutical company that develops therapies for acute and chronic gastrointestinal complications.

Pinnacle Medicines is a peptide drug discovery company that provides peptide modality for medical needs.

Inhibrx is a clinical-stage biotechnology company that focuses on developing a broad pipeline of biologic therapeutic candidates.

Ovid Therapeutic's purpose is to solve intractable medical problems.

Curevo is a clinical-stage biotechnology company developing next-generation, non-mRNA vaccines for infectious diseases.

Equillium is a biotechnology company that develops products for autoimmune and inflammatory disorders with an unmet medical need.

Dianthus Therapeutics is a biotech company developing new treatments for serious autoimmune diseases using a more targeted approach.

Angitia Biopharmaceuticals develops biologic therapies for musculoskeletal diseases.

Arcutis Biotherapeutics is a clinical-stage biopharmaceutical company focused on developing medical dermatology for unmet needs.

Zura Bio is a clinical-stage, multi-asset biotechnology company.

Bicara Therapeutics develops dual-action cancer therapies, combining targeted treatments with tumor modulators for enhanced impact.

Xilio Therapeutics is a biotechnology company that develops tumor-activated immuno-oncology therapies.

Indapta Therapeutics is a privately held biotechnology company.

Sparrow Pharmaceuticals is a clinical-stage biopharmaceutical company developing treatments for disorders of corticosteroid excess.

Gameto is a biotechnology company developing therapeutics of the female reproductive system using cell engineering.

Interius BioTherapeutics is a biopharmaceutical company that develops in vivo cell-specific gene medicines to treat B cell lymphomas.

Rampart Bioscience develops gene medicines to provide long-lasting treatments for a wide range of diseases.

Mariana Oncology is a biotechnology research industry.

ExcepGen is solving fundamental underlying problems in drug discovery to create a new generation of therapeutics.

Diagonal Therapeutics is a biotechnology startup that develops targeted therapies for cancer and genetic diseases.

Vaxcyte focuses on developing vaccines designed to prevent or treat some of the most common and deadly infectious diseases worldwide.

89bio is a biopharmaceutical company that develops clinical-stage therapies for liver and cardiometabolic diseases.

Triana Biomedicines is a developer of a molecular glue discovery platform to regulate disease.

Nodexus is democratizing access to live single cells for applications including gene editing, drug development, and more.

BioAge Labs is a clinical-stage biotechnology company that develops therapeutics to treat obesity and metabolic diseases.

Tenaya Therapeutics a clinical-stage biotechnology company that develops novel therapies to treat heart diseases.

Be Biopharma develops engineered B cell medicines for serious genetic diseases.

Antios Therapeutics is a biopharmaceutical company developing innovative therapies for viral diseases.

NanoMosaic provides solutions for early illness detection, prognostic monitoring, and biomarker identification.

Artios Pharma is a biopharmaceutical company that provides new solutions in the DNA damage response (DDR) field.

Metsera is a clinical‐stage biotech firm developing oral & injectable hormone therapies to treat obesity & related metabolic diseases.

TORL BioTherapeutics is a clinical-stage biopharmaceutical business.

Ervaxx is illuminating the immune interface to develop new cancer therapies.

Seres Therapeutics is a microbiome therapeutics company that develops treatments for serious diseases.

Aiolos Bio is a biotech company developing innovative therapies for respiratory diseases and immune conditions.

Cyteir is developing the next generation of synthetic lethal therapies to treat cancer.

LianBio aims to develop and accelerate availability of paradigm-shifting medicines to patients in China.

PMV Pharmaceuticals is a developer of p53-targeted small molecule drugs for the treatment of cancer.